esmolol

Key facts

Mechanism of action

Beta-1 adrenergic receptor antagonist

Approval history

1. EUCT 2024-511805-42 Phase 2 · Disc Medicine · Cardiogenic shock

1. AU 2013258031

   Parenteral esmolol formulation

   Expires Wed Nov 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

   granted →

Frequently asked questions